Works matching AU Ikegami, Yoji


Results: 14
    1
    2
    3
    4
    5
    6

    Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1299, doi. 10.1007/s00280-013-2307-6
    By:
    • Motoshima, Kohei;
    • Nakamura, Yoichi;
    • Sano, Kazumi;
    • Ikegami, Yoji;
    • Ikeda, Takaya;
    • Mizoguchi, Kosuke;
    • Takemoto, Shinnosuke;
    • Fukuda, Minoru;
    • Nagashima, Seiji;
    • Iida, Tetsuya;
    • Tsukamoto, Kazuhiro;
    • Kohno, Shigeru
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14